These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 18365788)

  • 1. [Impact of the obesity on the use of antipsychotic drugs in adult population attended in several primary care centers].
    Sicras-Mainar A; Rejas-Gutiérrez J; Navarro-Artieda R; Blanca-Tamayo M
    Actas Esp Psiquiatr; 2008; 36(2):90-3. PubMed ID: 18365788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency of new-onset diabetes mellitus and use of antipsychotic drugs among Central Texas veterans.
    Barner JC; Worchel J; Yang M
    Pharmacotherapy; 2004 Nov; 24(11):1529-38. PubMed ID: 15537558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphisms of the LEP- and LEPR gene and obesity in patients using antipsychotic medication.
    Gregoor JG; van der Weide J; Mulder H; Cohen D; van Megen HJ; Egberts AC; Heerdink ER
    J Clin Psychopharmacol; 2009 Feb; 29(1):21-5. PubMed ID: 19142102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic syndrome in bipolar disorder: a cross-sectional assessment of a Health Management Organization database.
    Sicras A; Rejas J; Navarro R; Serrat J; Blanca M
    Bipolar Disord; 2008 Jul; 10(5):607-16. PubMed ID: 18657245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Body composition in psychotic disorders: a general population survey.
    Saarni SE; Saarni SI; Fogelholm M; Heliövaara M; Perälä J; Suvisaari J; Lönnqvist J
    Psychol Med; 2009 May; 39(5):801-10. PubMed ID: 18713488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hospitalization risk associated with typical and atypical antipsychotic use in community-dwelling elderly patients.
    Aparasu RR; Jano E; Johnson ML; Chen H
    Am J Geriatr Pharmacother; 2008 Oct; 6(4):198-204. PubMed ID: 19028375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prehypertension, obesity, and risk of kidney disease: 20-year follow-up of the HUNT I study in Norway.
    Munkhaugen J; Lydersen S; Widerøe TE; Hallan S
    Am J Kidney Dis; 2009 Oct; 54(4):638-46. PubMed ID: 19515474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between resting heart rate and atherosclerosis risk factors.
    Piwońska A; Piotrowski W; Broda G; Drygas W; Głuszek J; Zdrojewski T; Kozakiewicz K; Stepaniak U; Bandosz P
    Kardiol Pol; 2008 Oct; 66(10):1069-75; discussion 1076-8. PubMed ID: 19006028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Estimation of the prevalence, incidence, comorbidities and direct costs associated to stroke patients requiring care in an area of the Spanish population].
    Fernández de Bobadilla J; Sicras-Mainar A; Navarro-Artieda R; Planas-Comes A; Soto-Alvarez J; Sánchez-Maestre C; Alvarez-Martín C; Ezpeleta-Echevarri D
    Rev Neurol; 2008 Apr 1-15; 46(7):397-405. PubMed ID: 18389458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-obesity drug use before professional treatment in Taiwan.
    Liou TH; Wu CH; Chien HC; Lin WY; Lee WJ; Chou P
    Asia Pac J Clin Nutr; 2007; 16(3):580-6. PubMed ID: 17704041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Body mass index and prevalence of obesity in a French cohort of patients with schizophrenia.
    Limosin F; Gasquet I; Leguay D; Azorin JM; Rouillon F
    Acta Psychiatr Scand; 2008 Jul; 118(1):19-25. PubMed ID: 18582344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic syndrome in Portugal: prevalence and implications for cardiovascular risk--results from the VALSIM Study.
    Fiuza M; Cortez-Dias N; Martins S; Belo A;
    Rev Port Cardiol; 2008 Dec; 27(12):1495-529. PubMed ID: 19280993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychological variables associated with weight loss in obese patients seeking treatment at medical centers.
    Dalle Grave R; Calugi S; Corica F; Di Domizio S; Marchesini G;
    J Am Diet Assoc; 2009 Dec; 109(12):2010-6. PubMed ID: 19942018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Body mass index and hypertension hemodynamic subtypes in the adult US population.
    Chirinos JA; Franklin SS; Townsend RR; Raij L
    Arch Intern Med; 2009 Mar; 169(6):580-6. PubMed ID: 19307521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Schizophrenia, obesity and pharmacotherapy-associated weight gain].
    Carpiniello B; Corda E; Maccioni R; Pinna F
    Clin Ter; 2008; 159(5):299-306. PubMed ID: 18998030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma cholesterol levels continue to decline despite the rising prevalence of obesity: population trends in Perth, Western Australia, 1980-1999.
    Hobbs MS; Knuiman MW; Briffa T; Ngo H; Jamrozik K
    Eur J Cardiovasc Prev Rehabil; 2008 Jun; 15(3):319-24. PubMed ID: 18525387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dimensions of socioeconomic position related to body mass index and obesity among Danish women and men.
    Groth MV; Fagt S; Stockmarr A; Matthiessen J; Biltoft-Jensen A
    Scand J Public Health; 2009 Jun; 37(4):418-26. PubMed ID: 19470691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obesity-related glomerulopathy in China: a case series of 90 patients.
    Chen HM; Li SJ; Chen HP; Wang QW; Li LS; Liu ZH
    Am J Kidney Dis; 2008 Jul; 52(1):58-65. PubMed ID: 18423814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends in prevalence of coronary risk factors in an urban Indian population: Jaipur Heart Watch-4.
    Gupta R; Kaul V; Bhagat N; Agrawal M; Gupta VP; Misra A; Vikram NK
    Indian Heart J; 2007; 59(4):346-53. PubMed ID: 19126941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of obesity on progression of non-diabetic chronic kidney disease: a retrospective cohort study.
    Othman M; Kawar B; El Nahas AM
    Nephron Clin Pract; 2009; 113(1):c16-23. PubMed ID: 19590231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.